This content is machine translated Program 2022 (2022) Dia-Month Club: Modules at a glance Here you can find the program of the Dia-Month Club 2022:
View Post 5 min This content is machine translated Modern lipid management Treating dyslipidemia in diabetes in a target-oriented manner Diabetes is associated with increased cardiovascular morbidity and mortality. Risk-stratified LDL cholesterol lowering is an important component of diabetes therapy and may improve clinical prognosis. In order to achieve the…
View Post 4 min This content is machine translated Inflammatory rheumatic diseases Targeted therapy in AS and PsA in use for over a year [1]. Ankylosing spondylitis (AS) and psoriatic arthritis (PsA) can cause permanent joint damage and significantly reduce the quality of life of those affected [2, 3]. For more than a year, an…
View Post 7 min This content is machine translated Type 2 diabetes: basal insulin therapy Lower risk of hypoglycemia with second-generation insulin analogues Type 2 diabetes develops insidiously over years and is usually diagnosed in middle to older adulthood – often incidentally during routine checkups. Adequate glycemic control is very important to prevent…
View Post 4 min This content is machine translated Type 2 diabetes and chronic renal failure (CKD) Dapagliflozin: risk reduction even in the presence of greatly increased albumin excretion. About half of all diabetics develop chronic kidney disease. SGLT-2 inhibitors have been shown not only to favorably affect glucose metabolism, but also to protect the heart and kidneys. The…
View Post 4 min This content is machine translated Early treatment of type 2 diabetes New study shows that optimal HbA1c values should be targeted from the time of diagnosis onwards In newly diagnosed type 2 diabetes, the risk of diabetic complications and death can be delayed by many years with the best possible glycemic control. That blood glucose levels early…
View Post 6 min This content is machine translated Management of rheumatoid arthritis “Anyone diagnosed with RA today wants to be completely symptom-free.” With the development of conventional, biologic, and targeted disease-modifying antirheumatic drugs, the prognosis for rheumatoid arthritis has improved significantly since the 1990s. However, many patients still do not respond to…
View Post 2 min This content is machine translated Type 2 diabetes and NAFLD Large waist circumference increases risk of severe liver damage Recent study data suggest an association between waist circumference and progression of nonalcoholic fatty liver disease (NAFLD) in people with type 2 diabetes. In NAFLD, fat accumulates in the liver,…
View Post 6 min This content is machine translated Valérie Krafft, Executive Director of the Rheumatism League Switzerland: “Rheumatic diseases still meet with a lot of misunderstanding from the public” The Swiss Rheumatism League has been working for people with rheumatism since 1958. In an interview, Executive Director Valérie Krafft explains how the non-profit organization supports those affected, why the…
View Post 5 min This content is machine translated The metabolic patient Type 2 diabetes: reducing cardiovascular risk through lipid lowering Diabetes is associated with increased cardiovascular risk. Multifactorial therapy of the four major risk factors of blood glucose, weight, hypertension, and dyslipidemia in individuals with type 2 diabetes is challenging.…
View Post 3 min This content is machine translated Type 2 diabetics with overweight Dulaglutide in higher dosage additionally promotes weight reduction GLP-1 receptor agonists not only improve glycemic control but also support weight loss and have also demonstrated additional cardio- and neprotective benefits. Dulaglutide (s.c.) has been successfully used for the…
